EUFEMED

What EUFEMED does

EUFEMED (European Federation for Exploratory Medicines Development) is a not-for-profit association established under Belgian law in 2015 and headquartered in Brussels. It is a federation of six national associations active in early clinical medicines development — Healixia (Belgium), Association Française de Pharmacologie Translationnelle (France), Association for Applied Human Pharmacology/Germany, Association for Human Pharmacology in the Pharmaceutical Industry (UK), the Polish Association for the Development of Innovative Medicines (Poland), and the Association of Clinical Research Organizations in the Netherlands. The organization's stated purpose is to act as a unified European voice for exploratory medicines development, representing member interests in regulatory consultations and developing standards and guidance documents for the field.

EUFEMED's core offerings consist of three revenue streams: (1) tiered membership subscriptions — €2,000 joining fee plus €2,000 annual fee for full national society members and €1,000/€1,000 for associate members (universities, foundations, commercial companies); (2) a modular Human Pharmacology Training Course aligned with the PharmaTrain syllabus, awarding 15 ECTS (certificate) and 30 ECTS (diploma) qualifications, including a Pre-Clinical and Clinical Safety module recognized by Paris-Saclay University; and (3) annual conferences (Brussels 2015, London 2017, Lyon 2019, virtual 2021, Brussels 2023, Mechelen 2025) plus Innovation Club webinars and CTR Reporting workshops. The organization has no proprietary software platform, no mobile app, and no API, and is staffed by 1–10 employees operating from a single Brussels office at Square de Meeûs 35.

EUFEMED has been formally recognized as a stakeholder by the European Medicines Agency and is consulted on revisions to European regulations and guidelines related to clinical drug development — its most distinctive asset. It is governed by a board including a President, Secretary, Treasurer, Communication Coordinator, President Elect, and Events Coordinator. The organization has no parent company, no funding rounds, no subsidiaries, and no equity instruments, consistent with its status as an ASBL owned and controlled by its member organizations.

Name

EUFEMED

Legal name

EUFEMED

Website

https://eufemed.eu

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

EUFEMED is a Brussels-based not-for-profit federation of six European national associations active in early clinical medicines development. It delivers PharmaTrain-aligned training courses, annual conferences, and EMA-recognized regulatory representation for early-phase clinical pharmacology professionals.

Ownership category

akta.pro rank

Product category

Professional Training and Education

NAICS

Professional and Management Development Training (611430), Technical and Trade Schools (6115)

SIC

Services-Educational Services (8200)

akta.pro industry

PRIMARYEDABALAU

Pharmaceuticals & Biotechnology

Education/Corporate Training & Professional Development/Industry-Specific Professional Training (e.g., Healthcare, Manufacturing, Construction)

SECONDARYEDAAANAI

Healthcare & Clinical Professional Certifications

Education/Adult & Continuing Education/Professional Certification Programs

SECONDARYEDAAALAC

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)

Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)

SECONDARYEDAOAJAO

Clinical Research Support (CRC/CTA)

Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

Keywords

• Human pharmacology training
• Early medicines development
• Clinical research education
• Exploratory drug development
• Pharmaceutical regulatory training

Headquarters

HQ city

Brussels

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Membership Fees: EUFEMED generates revenue through membership fees from national societies and associate members. Full membership requires €2000 joining fee and €2000 annual fee. Associate membership requires €1000 joining fee and €1000 annual fee.
2. Training Courses: Revenue from training programs including modules on exploratory medicines development, regulatory issues, study design, and clinical safety.
3. Conference and Event Fees: Revenue from annual conferences, workshops, and webinars on early clinical medicines development topics.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

EUFEMED delivers professional training courses, conferences, and workshops in human pharmacology and early clinical medicines development. Its flagship offering is a modular training course aligned with the PharmaTrain syllabus leading to certificate (15 ECTS) and diploma (30 ECTS) qualifications. It also organizes annual European conferences, pre-conference workshops, and Innovation Club webinars covering regulatory and scientific topics such as EU Clinical Trial Regulation implementation.

Product overview

EUFEMED is a not-for-profit association for early clinical medicines development, offering a modular Human Pharmacology Training Course leading to certificate (15 ECTS) and diploma (30 ECTS) qualifications. The training program comprises seven modules covering topics from introductory exploratory medicines development through Phase I Principal Investigator Training and Biologicals/Advanced Therapies. Additionally, EUFEMED organizes annual conferences in European cities and conducts Innovation Club workshops and webinars covering regulatory topics like the EU Clinical Trial Regulation implementation.

Differentiator

Problem solved

Functional benefit

Products and services

• EUFEMED Human Pharmacology Training Course

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Ten partnerships are on record, tiered core and minor.

• HealixiacoreOthers · 1 January 2025Healixia is a founding member of EUFEMED, formed in 2020 following merging of Belgian professional bodies (BAPU, ACRP.be, BeAPP and BRAS). Healixia represents Belgian professionals in research, development, medical affairs, safety, regulatory affairs and market access.
• Association Française de Pharmacologie Translationnelle (AFPT)coreOthers · 1 January 2025AFPT (formerly Club Phase I) is a founding member, a French non-profit association founded in 1993. Members are physicians and scientists from pharmaceutical industry, CROs and academia involved in human pharmacology and translational medicine.
• Association for Applied Human Pharmacology (AGAH)coreOthers · 1 January 2025AGAH is a founding member, a scientific medical not-for-profit organization founded in 1991. Members work in exploratory drug development and human pharmacology, including translational medicine professionals.
• Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)coreOthers · 1 January 2025AHPPI is a founding member and the oldest not-for-profit professional association involved in early phase drug development in the world, founded in 1988. Members include physicians, nurses, clinical scientists and project managers from pharmaceutical companies and CROs.
• Polish Association for the Development of Innovative Medicines (POLFEMED)minorOthers · 1 January 2022POLFEMED joined EUFEMED as full member in 2022. A non-profit organization dedicated to popularizing knowledge about clinical trials and promoting development and availability of modern therapies for patients in Poland.
• Association of Clinical Research Organizations in the Netherlands (ACRON)minorOthers · 1 January 2022ACRON joined EUFEMED as full member in 2022. A trade representative body for CROs in the Netherlands, involved in organizing meetings, networking, and lobbying for optimal research environment.
• ACCP (American College of Clinical Pharmacology)minorStrategic or Co-development Partner · 1 January 2016EUFEMED participated in ACCP Annual Conference 2016 with Symposium on 'Establishing Biosimilarity – The European Perspective'.
• European Medicines Agency (EMA)coreStrategic or Co-development PartnerEUFEMED has been recognized as a stakeholder by EMA and is consulted for the revision of important European regulations and guidelines related to clinical drug development. This is the organization's primary regulatory partnership providing legitimacy and policy influence.
• PharmaTraincoreStrategic or Co-development PartnerEUFEMED training course content is aligned with PharmaTrain syllabus developed jointly with Faculty of Pharmaceutical Medicine UK and IFAPP. EUFEMED maintains close alignment to ensure European acceptance of its human pharmacology course.
• Paris-Saclay UniversitycoreStrategic or Co-development PartnerTraining course 'Pre-Clinical and Clinical Safety in Early Development Human Trials' is recognized by Paris-Saclay University and forms part of the EUFEMED diploma program.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Healixia: Healixia is a Belgian founding member of EUFEMED that itself provides Belgian-level professional training, events, and networking for clinical research, regulatory, and medical affairs professionals. It is an adjacent but more nationally scoped organization with overlapping training offerings.
• Barnett International: Barnett International delivers professional training and certification preparation for clinical research and pharmacovigilance professionals. It is a commercial alternative to EUFEMED's training programs, particularly in the US, with overlapping curriculum on early-phase development and GCP.
• PRIME (Pharmacology Research Institute for Medicines and Education): PRIME-style regional bodies represent another tier of professional societies in human pharmacology and early drug development that intersect with EUFEMED's scope but typically at national or sub-regional level rather than pan-European.

Direct peers

• PharmaTrain Federation: PharmaTrain is a not-for-profit federation that develops the syllabus and standards for training in pharmaceutical medicine. EUFEMED explicitly aligns its training curriculum with PharmaTrain, making it the most direct peer in the pharmaceutical training standards space.
• IFAPP (International Federation of Associations of Pharmaceutical Physicians): IFAPP is a global federation of national associations for pharmaceutical physicians, co-developer of the PharmaTrain syllabus with EUFEMED's content. Both target the same audience of pharma physicians and offer continuing education aligned with shared standards.
• EFGCP (European Forum for Good Clinical Practice): EFGCP is a European not-for-profit focused on good clinical practice and clinical trial conduct, including multi-stakeholder workshops on trial result communication. EUFEMED and EFGCP operate in adjacent regulatory and training spaces for clinical research professionals.

Broad incumbents

• ACRP (Association of Clinical Research Professionals): ACRP is a large global membership organization offering clinical research certification (CCRA, CCRC) and training. While US-rooted and broader in scope, ACRP targets the same pool of investigators and clinical research staff that EUFEMED trains in Phase I trials.
• DIA (Drug Information Association): DIA is a major global neutral forum and training provider across the full drug development lifecycle. It overlaps with EUFEMED on regulatory affairs, early-phase development, and clinical trial training, but at significantly larger scale and broader scope.
• Faculty of Pharmaceutical Medicine (FPM) UK: FPM is the UK professional membership body for pharmaceutical physicians offering training, certification (e.g., DPM), and CPD. It is broader in scope than EUFEMED's early-phase focus but serves overlapping clinical research professionals in the same PharmaTrain ecosystem.
• ACCP (American College of Clinical Pharmacology): ACCP is a US-based professional society for clinical pharmacology with EUFEMED's listed partnership history (2016 symposium). It addresses a closely adjacent audience in clinical pharmacology education and Phase I research but at larger scale in North America.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/EUFEMED
• Facebookfacebook.com/EUFEMED
• LinkedInlinkedin.com/company/eufemedeu

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EUFEMED